search

Vichy Neovadiol Meno 5 Bi-Serum Slackening & Dark Spots 30 ml


€41.36

Vichy Neovadiol Meno 5 Bi-Serum Slackening & Dark Spots 30 ml is a serum designed to compensate for the visible impacts of menopause on the skin. It brings 5 benefits: redefined contours, brightness, nutrition, anti-wrinkle, anti-brown spots.

Indication: Peri & post-menopausal face care.

48 hours
Qty
In stock

Description Vichy Neovadiol Meno 5 Bi-Serum Slackening & Brown Spots 30 ml

Vichy Neovadiol Meno 5 Bi-Serum Slackening & Dark Spots 30 ml is a serum designed to compensate for the visible impacts of menopause on the skin.

It provides 5 benefits: redefined contours, radiance, nutrition, anti-wrinkle, anti-brown spots.

Its formula combines Vichy Volcanic Water, rich in 15 minerals, with densifying Proxylane, Cassia extract, a trio of vitamins B3-Cg-E, and Omegas from vegetable oils.

The contours are resculpted, wrinkles and brown spots are corrected. Relipidated, the skin finds its glare.

Dermatologically tested, even on sensitive skin.

Made in France.

Councils of use Vichy Neovadiol Meno 5 Bi-Serum Relâchement & Taches Brunes 30 ml

Shake well before use.

Apply morning and evening before your cream.

Avoid the eye and lip area. In case of contact with the eyes, rinse thoroughly.

In case of discomfort, space out the applications. If it persists, stop using the product.

Avoid prolonged exposure to the sun. To be used with a sun protection SPF>20.

COMPOSITION

Aqua/Water/Eau, Isopropyl Isostearate, Dicaprylyl Ether, Niacinamide, Propylene Glycol, Glycolic Acid, Squalane, Alcohol Denat, Glycerin, Dipropylene Glycol, Sodium Hydroxide, Tocopherol, Haematococcus Pluvialis Extrcat, Prunus Armeniaca Kernel Oil/Apricot Kernel Oil, Adenosine, Ascorbyl Glucoside, Isopropyl Lauroyl Sarcosinate, Hydroxyacetophenone, Hydroxypropyl-Tetrahydropyrantriol, Capryloyl Salicylic Acid, Caprylic/Capric Trigléceride, Cassia Angustifolia Seed Polysaccharide, Parfum/Fragrance.

3337875773980

Specific References

chat Comments (0)
No customer reviews for the moment.